These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28228411)

  • 1. Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema.
    Wickremasinghe SS; Fraser-Bell S; Alessandrello E; Mehta H; Gillies MC; Lim LL
    Br J Ophthalmol; 2017 Oct; 101(10):1329-1333. PubMed ID: 28228411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.
    Mehta H; Fraser-Bell S; Yeung A; Campain A; Lim LL; Quin GJ; McAllister IL; Keane PA; Gillies MC
    Br J Ophthalmol; 2016 Jul; 100(7):1000-1004. PubMed ID: 26537156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.
    Kim M; Cho YJ; Lee CH; Lee SC
    Eye (Lond); 2016 May; 30(5):718-25. PubMed ID: 26939558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
    Wickremasinghe SS; Rogers SL; Gillies MC; Zhu M; Wong TY
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4707-11. PubMed ID: 18599569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.
    Soliman W; Vinten M; Sander B; Soliman KA; Yehya S; Rahman MS; Larsen M
    Acta Ophthalmol; 2008 Jun; 86(4):365-71. PubMed ID: 18028237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumab.
    Moradi A; Sepah YJ; Ibrahim MA; Sophie R; Moazez C; Bittencourt MG; Annam RE; Hanout M; Liu H; Ferraz D; Do DV; Nguyen QD;
    Eye (Lond); 2014 Nov; 28(11):1315-20. PubMed ID: 25145456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
    Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC
    Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA.
    Shah SU; Harless A; Bleau L; Maturi RK
    Retina; 2016 Oct; 36(10):1986-96. PubMed ID: 27124881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
    Danis RP; Sadda S; Li XY; Cui H; Hashad Y; Whitcup SM
    Br J Ophthalmol; 2016 Jun; 100(6):796-801. PubMed ID: 26581718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema.
    Aroney C; Fraser-Bell S; Lamoureux EL; Gillies MC; Lim LL; Fenwick EK
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5541-5546. PubMed ID: 27768792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
    Busch C; Zur D; Fraser-Bell S; Laíns I; Santos AR; Lupidi M; Cagini C; Gabrielle PH; Couturier A; Mané-Tauty V; Giancipoli E; Ricci GD; Cebeci Z; Rodríguez-Valdés PJ; Chaikitmongkol V; Amphornphruet A; Hindi I; Agrawal K; Chhablani J; Loewenstein A; Iglicki M; Rehak M;
    Acta Diabetol; 2018 Aug; 55(8):789-796. PubMed ID: 29730822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.